Journal article

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia

Sue Furness, Helen Roberts, Jane Marjoribanks, Anne Lethaby, Martha Hickey, Cindy Farquhar

COCHRANE DATABASE OF SYSTEMATIC REVIEWS | WILEY | Published : 2009

Abstract

BACKGROUND: Declining circulating estrogen levels around the time of the menopause can induce unacceptable symptoms that affect the health and well being of women. Hormone therapy (both unopposed estrogen and estrogen/progestogen combinations) is an effective treatment for these symptoms, but is associated with risk of harms. Guidelines recommend that hormone therapy be given at the lowest effective dose and treatment should be reviewed regularly. The aim of this review is to identify the minimum dose(s) of progestogen required to be added to estrogen so that the rate of endometrial hyperplasia is not increased compared to placebo. OBJECTIVES: The objective of this review is to assess which ..

View full abstract